Allogeneic Cardiosphere-Derived Cells (CAP-1002)

BIOLOGICAL2 trials

Sponsors

Capricor Inc.

Conditions

CardiomyopathyDuchenne Muscular Dystrophy

Phase 2

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

CompletedNCT02485938

Capricor Inc.Cardiomyopathy, Duchenne Muscular Dystrophy

Start: 2016-01-07End: 2017-09-14Updated: 2025-01-09

Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)

CompletedNCT06304064

Capricor Inc.Duchenne Muscular Dystrophy

Start: 2018-06-21End: 2019-03-06Updated: 2024-04-24

Related Papers

Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial.

2019-01-2359 citations